HomeCompareACWRF vs MRK

ACWRF vs MRK: Dividend Comparison 2026

ACWRF yields 153846.15% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ACWRF wins by $3.570817397657267e+28M in total portfolio value
10 years
ACWRF
ACWRF
● Live price
153846.15%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.570817397657267e+28M
Annual income
$35,662,574,083,913,823,000,000,000,000,000,000.00
Full ACWRF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ACWRF vs MRK

📍 ACWRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodACWRFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ACWRF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ACWRF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ACWRF
Annual income on $10K today (after 15% tax)
$13,076,923.08/yr
After 10yr DRIP, annual income (after tax)
$30,313,187,971,326,747,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, ACWRF beats the other by $30,313,187,971,326,747,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ACWRF + MRK for your $10,000?

ACWRF: 50%MRK: 50%
100% MRK50/50100% ACWRF
Portfolio after 10yr
$1.7854086988286334e+28M
Annual income
$17,831,287,041,956,911,000,000,000,000,000,000.00/yr
Blended yield
99.87%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ACWRF
No analyst data
Altman Z
-107.2
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ACWRF buys
0
MRK buys
0
No recent congressional trades found for ACWRF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricACWRFMRK
Forward yield153846.15%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$3.570817397657267e+28M$56.8K
Annual income after 10y$35,662,574,083,913,823,000,000,000,000,000,000.00$9,798.13
Total dividends collected$3.5705187474861104e+28M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ACWRF vs MRK ($10,000, DRIP)

YearACWRF PortfolioACWRF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$15,395,315$15,384,615.38$11,206$366.19+$15.38MACWRF
2$22,152,081,017$22,135,608,029.64$12,650$502.35+$22152.07MACWRF
3$29,790,603,453,124$29,766,900,726,435.82$14,407$694.19+$29790603.44MACWRF
4$37,444,193,407,360,220$37,412,317,461,665,380.00$16,585$967.82+$37444193407.34MACWRF
5$43,987,751,239,956,050,000$43,947,685,953,010,180,000.00$19,342$1,363.89+$43987751239956.04MACWRF
6$48,297,311,048,679,450,000,000$48,250,244,154,852,700,000,000.00$22,913$1,947.19+$48297311048679448.00MACWRF
7$49,563,274,505,183,440,000,000,000$49,511,596,382,361,350,000,000,000.00$27,662$2,823.89+$49563274505183444992.00MACWRF
8$47,538,442,557,656,110,000,000,000,000$47,485,409,853,935,560,000,000,000,000.00$34,159$4,173.35+$4.753844255765611e+22MACWRF
9$42,616,722,111,071,980,000,000,000,000,000$42,565,855,977,535,280,000,000,000,000,000.00$43,337$6,308.80+$4.261672211107198e+25MACWRF
10$35,708,173,976,572,667,000,000,000,000,000,000$35,662,574,083,913,823,000,000,000,000,000,000.00$56,776$9,798.13+$3.570817397657267e+28MACWRF

ACWRF vs MRK: Complete Analysis 2026

ACWRFStock

Acceleware Ltd. operates as an oil and gas technology company in Canada and the United States. The company operates through two segments, RF Heating and High-Performance Computing. It develops an enhanced heavy oil and oil sands production technology based on radio frequency (RF) heating; and develops and markets computational software products for the oil and gas, and other markets. The company's solutions include AxFDTD, an electromagnetic modeling software to measure RF energy absorption; AxHeat RF heating simulation software; AxRTM, a graphics processing unit accelerated Kirchhoff time migration solution; AxWAVE, a solution that allows customers to model seismic acquisition and perform data characterization; AxFWI, a revolutionary modular full waveform inversion application for providing subsurface velocity models. It also sells computing software and related consulting services, and training programs primarily to the oil and gas industry. The company was founded in 2004 and is headquartered in Calgary, Canada.

Full ACWRF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ACWRF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ACWRF vs SCHDACWRF vs JEPIACWRF vs OACWRF vs KOACWRF vs MAINACWRF vs JNJACWRF vs ABBVACWRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.